The level of scientific understanding required to develop a successful AIDS vaccine is still lacking, although the elements needed to pursue a practical and productive vaccine development program can be defined.
Article PDF
References
Scientific and public health rationale for HIV vaccine efficacy trials. AIDS 9, WHO1–WHO4 (1995).
Hilleman, M.R., Practical insights from comparative immunology and pathogenesis of AIDS, hepatitis, and measles for developing an HIV vaccine. Vaccine (in the press).
Donnelly, J.J. et al. Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus. Nature Med. 1, 583–587 (1995).
Rimmelzwaan, G.F. & Osterhaus, A.D.M.E. Cytotoxic T lymphocyte memory: Role in cross-protective immunity against influenza? Vaccine 13, 703–705 (1995).
Hilleman, M.R. Comparative biology and pathogenesis of AIDS and Hepatitis B viruses: Related but different. AIDS Res. hum. Retrovir. 10, 1409–1419 (1994).
Hilleman, M.R., cinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS. AIDS Res. hum. Retrovir. 10, 3–12 (1994).
Griffin, D., Ward, B. & Esolen, L.M. Pathogenesis of measles virus infection: An hypothesis of altered immune responses. J. infect. Dis. 170 (suppl.), S24–S31 (1994).
Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K. & Desrosiers, R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938–1941 (1992).
Baba, T.W. et al. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 427, 1820–1825 (1995).
Ho, D.D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995).
Pantaleo, G., Graziosi, C. & Fauci, A.S. The immunopathogenesis of human immunodeficiency virus infection. New Engl. J. Med. 328, 327–335 (1993).
Levy, J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183–289 (1993).
Kurth, R. et al. Pathogenic mechanisms in HIV and SIV infections. in Animal Models of HIV and Other Retroviral Infections (eds Racz, P., Letvin, N.L. & Gluckman, J.D.) 39–48 (Karger, Basel, 1993).
Clerici, M. & Shearer, G.M. A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immun. Today 114, 107–111 (1993).
Mosmann, T.R. Cytokine patterns during the progression to AIDS. Science 265, 193–194 (1994).
Ennen, J. et al. CD8+ T lymphocytes of African Green Monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc. natn. Acad. Sci. U.S.A. 91, 7207–7214 (1994).
Hilleman, M.R., Impediments, imponderables and alternatives in the attempt to develop an effective vaccine against AIDS. Vaccine 10, 1053–1058 (1992).
Fields, B.N. AIDS: Time to turn to basic science. Nature 369, 95–96 (1994).
Paul, W.E. Reexamining AIDS research priorities. Science 267, 633–636 (1995).
Simon-Moffat, A. Exploring transgenic plants as a new vaccine source. Science 268, 658–660 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hilleman, M. Whether and when an AIDS vaccine?. Nat Med 1, 1126–1129 (1995). https://doi.org/10.1038/nm1195-1126
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1195-1126
This article is cited by
-
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
Nature Medicine (1997)
-
Mother–infant HIV transmission: Making the most of what we know
Nature Medicine (1996)
-
Progress and challenges toward an AIDS vaccine: Brother, can you spare a paradigm?
Journal of Clinical Immunology (1996)